Skip to content
Innovative Tech
Diseases
Health Policy
HTA
Data Analysis
Clinical Practice
Contributors
BACK TO MAIN SITE
Cost Savings on Generic Drugs: Transparent Pric...
By
HEOR Staff Writer
June 18, 2024
Introduction Through its transparent, online direct-to-consumer pharmacy model, the Mark Cuban Cost Plus Drug Company (MCCPDC) has made substantial progress in the provisi...
Introducing GRACE for Patient-Centric Care
Rethinking Health State Valuation: Moving Beyond ‘Dead’ as an Anchor
Making Better Choices in Diabetes Care With Multi-criteria Decision Making (M...
The Power of Real-World Evidence: Bringing Everyday Health Data to Drug Appro...
Healthcare Decision-Making with MCDA Framework: The Saudi Arabian Perspective
Economic Evaluations for Dementia Interventions
The Shifting Nature and Impact of Health Technology Assessment
Sustainable Pricing in Diabetes: Cost-Effective Medication Access
Medical AI Future: Sustainable Reimbursement Strategies
The Influence of AI on Risk Adjustment Models in Healthcare
Innovative Technology Policy: Simulation Modelling in Healthcare
Policy of Innovative Health Technology: Biobanks in Abu Dhabi
« Previous
1
…
3
4
5
6
7
…
10
Next »